We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTempleton Emerging Markets Regulatory News (TEM)

Share Price Information for Templeton Emerging Markets (TEM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 149.20
Bid: 148.80
Ask: 149.20
Change: -1.80 (-1.19%)
Spread: 0.40 (0.269%)
Open: 148.20
High: 149.20
Low: 148.20
Prev. Close: 151.00
TEM Live PriceLast checked at -
Templeton Emerging Markets is an Investment Trust

To provide long-term capital appreciation for private and institutional investors seeking exposure to global emerging markets, supported by both strong customer service and corporate governance.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Edison review on Templeton Emerging Markets IT

18 Jun 2020 16:16

RNS Number : 4211Q
Templeton Emerging Markets IT PLC
18 June 2020
 

 

London, UK, 18 June 2020

Edison review on Templeton Emerging Markets IT (TEM)

Templeton Emerging Markets Investment Trust's (TEMIT) two managers have more than 50 years' combined investment experience. Chetan Sehgal is based in Singapore and Andrew Ness is based in Edinburgh; they are part of a more than 80-strong team of portfolio managers and analysts across 16 countries around the globe. The trust's relative performance was negatively affected during the coronavirus-led market sell-off earlier in 2020 but has since bounced back strongly. TEMIT has outperformed its benchmark, the MSCI Emerging Markets index, over the last one, three, five and 10 years in both NAV and share price terms.

 

TEMIT's current 11.6% discount to cum-income NAV is broadly in line with the 10.3% to 12.1% range of average discounts over the last one, three, five and 10 years. Over the last 12 months the trust has traded in a range of discounts from 8.7% to a decade-wide 19.9%. TEMIT has meaningfully grown its annual dividends in recent years and currently offers a 2.5% yield.

Click here to view the full report.

 

Subscribe to Edison's content to receive reports by email.

All reports published by Edison are free-to-access and available on the website.

 

About Edison: Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world-renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisers and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information please contact Edison:

Mel Jenner, +44 (0)20 3077 5720

Sarah Godfrey, +44 (0)20 3681 2519

investmenttrusts@edisongroup.com

 

Learn more at www.edisongroup.com and connect with Edison on:

LinkedIn https://www.linkedin.com/company/edison-group- 

Twitter www.twitter.com/Edison_Inv_Res 

YouTube www.youtube.com/edisonitv 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAEVLFFBQLFBBZ
Date   Source Headline
19th Apr 20248:48 amRNSNet Asset Value(s)
18th Apr 20244:46 pmRNSTransaction in Own Shares
18th Apr 20248:55 amRNSNet Asset Value(s)
17th Apr 20244:52 pmRNSTransaction in Own Shares
17th Apr 20249:03 amRNSNet Asset Value(s)
16th Apr 20245:05 pmRNSTransaction in Own Shares
16th Apr 20248:36 amRNSNet Asset Value(s)
15th Apr 20244:54 pmRNSTransaction in Own Shares
15th Apr 20249:00 amRNSNet Asset Value(s)
12th Apr 20244:51 pmRNSTransaction in Own Shares
12th Apr 20249:06 amRNSNet Asset Value(s)
11th Apr 20244:54 pmRNSTransaction in Own Shares
11th Apr 20248:43 amRNSNet Asset Value(s)
10th Apr 20244:53 pmRNSTransaction in Own Shares
10th Apr 20248:52 amRNSNet Asset Value(s)
9th Apr 20245:02 pmRNSTransaction in Own Shares
9th Apr 20248:52 amRNSNet Asset Value(s)
8th Apr 20244:53 pmRNSTransaction in Own Shares
8th Apr 20248:49 amRNSNet Asset Value(s)
5th Apr 20248:46 amRNSNet Asset Value(s)
4th Apr 20248:43 amRNSNet Asset Value(s)
3rd Apr 20244:13 pmRNSHolding(s) in Company
3rd Apr 20249:15 amRNSNet Asset Value(s)
2nd Apr 20245:00 pmRNSTransaction in Own Shares
2nd Apr 202410:40 amRNSNet Asset Value(s)
2nd Apr 20249:16 amRNSTotal Voting Rights
2nd Apr 20247:00 amRNSNet Asset Value(s)
28th Mar 20249:11 amRNSNet Asset Value(s)
27th Mar 20245:01 pmRNSTransaction in Own Shares
27th Mar 20249:04 amRNSNet Asset Value(s)
26th Mar 20245:03 pmRNSTransaction in Own Shares
26th Mar 20249:10 amRNSNet Asset Value(s)
25th Mar 20244:54 pmRNSTransaction in Own Shares
25th Mar 20248:59 amRNSNet Asset Value(s)
22nd Mar 20244:56 pmRNSTransaction in Own Shares
22nd Mar 20248:23 amRNSNet Asset Value(s)
21st Mar 20248:54 amRNSNet Asset Value(s)
20th Mar 20245:00 pmRNSTransaction in Own Shares
20th Mar 20249:40 amRNSPortfolio Update
20th Mar 20248:52 amRNSNet Asset Value(s)
19th Mar 20244:52 pmRNSTransaction in Own Shares
19th Mar 20248:52 amRNSNet Asset Value(s)
18th Mar 20248:42 amRNSNet Asset Value(s)
15th Mar 20245:03 pmRNSTransaction in Own Shares
15th Mar 20248:53 amRNSNet Asset Value(s)
14th Mar 20245:15 pmRNSTransaction in Own Shares
14th Mar 20248:30 amRNSNet Asset Value(s)
13th Mar 20245:03 pmRNSTransaction in Own Shares
13th Mar 20244:15 pmRNSDirectorate Change
13th Mar 20248:54 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.